Results for t2 translation from Croatian to English

medijan % promjene volumena hiperintenzivnih lezija t2
median % change in t2- hyperintense lesion volume

srednji broj novih ili novorastućih hiperintenzivnih lezija t2
mean number of new or newly- enlarging t2-hyperintense lesions

bolesnici s novim ili povećanim t2 lezijama tijekom 2. godine
patients with new or enlarging t2 lesions through year 2

atraktivno zemljište u t1/ t2 zoni , udaljeno 80 m od mora .
attractive building plot in t1/ t2 zone , 80 m from the sea .

mr t2* vrijednosti miokarda manje od 20 milisekundi predstavljaju preopterećenje srca željezom.
myocardial mri t2* values of less than 20 milliseconds represent iron overload in the heart.

medijan (srednja vrijednost) broja novih ili povećanih t2 lezija tijekom 12 mjeseci
median (mean) number of new or enlarging t2 lesions over 12 months

pri oštećenju kmb, molekule gadoversetamida šire se u intersticijski odjeljak i time stvaraju karakteristični paramagnetski učinak skraćivanja t1 i t2.
when the bbb is disrupted, the gadoversetamide molecules diffuse into the interstitial compartment thereby producing the characteristic paramagnetic effect of t1 and t2 shortening.

unutar tog razdoblja, razvoj neutralizirajuće aktivnosti bio je povezan sa značajnim porastom u nanovo aktiviranim lezijama te volumenu t2 lezija na snimkama dobivenim magnetskom rezonancijom.
within this period, the development of neutralising activity was associated with a significant increase in newly active lesions and t2 lesion volume on magnetic resonance imaging.

38% s najmanje 1 gd+ lezijom na početku 92% ≥9 t2 lezija na početku
38% at least 1 gd+ lesion at baseline 92% ≥9 t2 lesions baseline

doza od 2 mg/kg sugamadeksa preporučuje se u slučaju da je nakon blokade izazvane rokuronijem ili vekuronijem nastupio spontani oporavak do najmanje one razine pri kojoj se ponovno pojavio t2.
a dose of 2 mg/kg sugammadex is recommended, if spontaneous recovery has occurred up to at least the reappearance of t2 following rocuronium or vecuronium induced blockade.

bolesnici izloženi plegridyju svaka 2 tjedna pokazali su statistički značajna smanjenja u odnosu na bolesnike koji su bili izloženi plegridyju svaka 4 tjedna tijekom 2 godine u post-hoc analizi ishoda uključujući arr (24%, p=0,0209), rizik od relapsa (24%, p=0,0212), rizik od progresije onesposobljenosti potvrđen u 24. tjednu (36%, p = 0,0459), i mr ishode (nove/povećane t2 60%, gd+ 71%, i nove t1 hipointenzivne lezije 53%; p <0,0001 za sve.)
patients exposed to plegridy every 2 weeks showed statistically significant reductions compared to patients exposed to plegridy every 4 weeks over 2 years in a post-hoc analysis for endpoints including arr (24%, p=0.0209), the risk of relapse (24%, p=0.0212), the risk of disability progression with 24 week confirmation (36%, p=0.0459), and mri endpoints (new/enlarging t2 60%, gd+ 71%, and new t1 hypointense lesions 53%; p<0.0001 for all).